New York State Psychiatric Institute (NYSPI) is a clinical research site located in New York, New York, United States 10032.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
New York State Psychiatric Institute (NYSPI) has participated in 3 clinical trials with 3 currently active.
Therapeutic areas: 16P11.2 Deletion Syndrome, Generalized Anxiety Disorder, Major Depressive Disorder (MDD).
Sponsors: Clinical Research Associates, LLC, Definium Therapeutics US, Inc., Jeffrey Miller.
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
New York State Psychiatric Institute (NYSPI) has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York State Psychiatric Institute (NYSPI) has 3 clinical trials on record, with 3 currently active. Their work covers 16P11.2 Deletion Syndrome, Generalized Anxiety Disorder, Major Depressive Disorder (MDD).
New York State Psychiatric Institute (NYSPI) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.